The masterbrain's trajectory (blue, curved through its 7 checkpoints), the deterministic v0.3 control (dashed), and the actual price (green) overlaid from the prediction date forward.
Forecast Change+9.6% to $32.30
Predicted High$32.30at 6 months
Predicted Low$29.15at 1 month
Max Drawdown (predicted)-1.1%
Forecast
The masterbrain trajectory — 7 dated checkpoints. Short rungs (2w, 1m) show the typical range as the primary claim; point calls run from 2 months out. Every claim still gets graded.
Predicted Aug 14, 2026 3:25 am
Bull
IBN trends higher to
$32.30
(+9.6% from $29.48)
by Feb 2027.
dip-then-recover
ThesisIBN trades far below quality-driven fair value anchors but low beta and inert sentiment mean convergence is slow; expect a modest grind higher toward the prior prediction's $32-33 zone, not the extreme DCF endpoint.
Invalidated ifA close below $26.50 sustained for two weeks, or a break of the risk-on regime, would falsify the gradual recovery thesis.
Checkpointtime after the call
Datewhen it gets graded
Predictedthe claim: closing price
Current priceactual close — fills in over time
Predicted returnpredicted vs $29.48 at call
Conv.brain's confidence, 1–10
Driverwhy the brain put the point here
Prediction made
Aug 14, 2026
—
$29.48at call
—
—
The anchor — every point below is measured from this price and date.
2 weeks
Aug 28, 2026
$28.30–$30.66typical range · internal point $29.35
—
±4.0%
6/10
Low-vol drift, no catalyst, mild sentiment inertia
1 month
Sep 14, 2026
$27.77–$31.19typical range · internal point $29.15
—
±5.8%
5/10
Slight dip on trailing weakness, value zone approached
2 months
Oct 14, 2026
$29.80
—
+1.1%
5/10
Value buyers absorb near attractive threshold
3 months
Nov 14, 2026
$30.40
—
+3.1%
5/10
Quality re-rating begins, regime supportive
4 months
Dec 14, 2026
$31.10
—
+5.5%
4/10
Year-end positioning favors high-quality EM banks
5 months
Jan 14, 2027
$31.70
—
+7.5%
4/10
Earnings expectation build, gradual multiple lift
6 months
Feb 14, 2027
$32.30
—
+9.6%
4/10
Convergence toward prior model endpoint, low beta caps upside
Why ranges on the short rungs?
A 102-prediction trial (2026-07-21) showed 2-week point calls carry no information here —
three prompt formulations all lost to simply predicting zero — while the stock's own
volatility scale (σ×√t) described those windows well. So the short rungs claim what's
actually knowable: the typical travel, with earnings timing flagged where the variance
will come from. The internal point calls keep being generated and graded to map where
real skill begins. Full evidence: stocks/predictions/V0.5-DESIGN.md §8.
Deterministic control (v0.3 value line) targets
$128.88
(+337.2%)
— both lines get graded at every checkpoint, so the brain has to beat the formula, not just replace it.
Brain: claude-opus-4-7.